Germany· DE-A57-38dcd7836d6fc456
Daptomycin Puren
A daptomycin product containing daptomycin, registered in Germany by Eugia Pharma (Malta) Limited. The same ATC class is registered in 17 of our 19 countries.
Checked against EMA Article 57 (European Union) on
Informational only — not a medical device.
Where it is registered
Daptomycin is registered in 17 of 19 countries.
Countries holding a registration under ATC J01XX09 (daptomycin), each read from that country’s own register.
- This record: Germany, from EMA Article 57 (European Union)
- 9 of them publish a price we can compare per daily dose
Daptomycin · ATC J01XX09
17 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of daptomycin costs, country by country.
Normalised to the WHO defined daily dose (0.28 g), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Daptomycin · price per daily dose (0.28 g)
USD · FX 28 Sept 2026
- CH Switzerland$88.75
The record
At a glance
EMA Article 57 (European Union)- Active substance
- Daptomycin
- Manufacturer
- Eugia Pharma (Malta) Limited
- Country
- Germany (DE)
- ATC code
- J01XX09
- ATC class
- Daptomycin
- Defined daily dose
- 0.28 g, P
- Reimbursed
- Not published by this register
- Source register
- EMA Article 57 (European Union)
- Last checked
- September 30, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
25 interactions on record for daptomycin.
Graded by severity as the source publishes them — 18 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Daptomycin · interactions on record
25 records
- 18 moderate
- 2 minor
Most severe, free to view
- Sodium picosulfateA06AB08moderate
- IbuprofenC01EB16moderate
- SimvastatinC10AA01moderate
- RosuvastatinC10AA07moderate
5 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Daptomycin in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesdaptomycinSlate Run Pharmaceuticals, LLC
- SpainCUBICIN 350 MG POLVO PARA SOLUCION INYECTABLE Y PARA PERFUSIONMerck Sharp & Dohme B.V.
- United KingdomCubicin 350mg powder for concentrate for solution for infusion vialsMerck Sharp & Dohme (UK) Ltd
- FranceCUBICIN 350 mg, poudre pour solution injectable ou pour perfusionMERCK SHARP & DOHME (PAYS-BAS)
- SwedenCubicin 350 mg Pulver till injektions-/infusionsvätska, lösningMerck Sharp & Dohme BV
- FinlandCubicinMerck Sharp & Dohme B.V.
- IrelandCubicin 350 mg powder for solution for injection or infusionMerck Sharp & Dohme BV
- NetherlandsCubicin 350 mg, poeder voor oplossing voor injectie of infusieMerck Sharp & Dohme B.V.
Authorised across Europe · EMA
The same active substance is authorised in 27 EEA countries. Names it is sold under:
- Austria · Daptomycin Accord Healthcare, Daptomycin Accordpharma
- Belgium · Daptomycine Hikma
- Bulgaria · Даптомицин Mip
- Cyprus · Daptomycin Cooper 350mg, Daptomycin Cooper 500mg
- Czechia · Daptomycin Accordpharma
- Denmark · Daptomycin "hameln", Daptomycin Accord Healthcare
- Estonia · Daptomycin Norameda
- Spain · Daptomicin Tarbis, Daptomicina Accord
- Finland · Daptomycin Accord Healthcare, Daptomycin Accordpharma
- France · Daptomycin Fosun Pharma, Daptomycin Tillomed
- United Kingdom (Northern Ireland) · Daptomycin, Daptomycin Accord Healthcare
- Greece · Daptomycin Accord Healthcare, Daptomycin Accordpharma
- Croatia · Daptomicin Accord Healthcare, Daptomicin Accordpharma
- Hungary · Daptomycin Anfarm, Daptomycin Hameln
- Ireland · Daptomycin Accord Healthcare, Daptomycin Accordpharma
- Iceland · Cubicin, Daptomycin Hameln
- Italy · Daptomicina Accord, Daptomicina Accordpharma
- Liechtenstein · Cubicin, Daptomycin Hospira
- Luxembourg · Daptomycin Eberth, Daptomycine Hikma
- Malta · Daptomycin Anfarm, Daptomycin Dr. Reddys
- Netherlands · Daptomicin Accord Healthcare, Daptomicine Accord Healthcare
- Norway · Cubicin, Daptomycin Accord Healthcare
- Poland · Daptomicina Fosun Pharma, Daptomycin Accord Healthcare
- Portugal · Daptomicina Accord Healthcare, Daptomicina Accordpharma
- Romania · Daptomicină Dr. Reddy’s, Daptomicină Mip
- Sweden · Daptomycin Accord Healthcare, Daptomycin Accordpharma
- Slovenia · Daptomicin Accord Healthcare, Daptomicin Accordpharma
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of EMA Article 57 (European Union). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f0741268-9467-4e07-8cee-de2474d92d1d GET /v1/drugs/f0741268-9467-4e07-8cee-de2474d92d1d?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"pzn": null,
"route": "Intravenous Use",
"source": "ema_art57_de",
"ma_number": null,
"substance": "Daptomycin",
"atc_from_source": null,
"authorisation_country": "Germany"
}See everything about daptomycin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.